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Questions: Does a 3-month behaviour change intervention targeting physical activity (PA) increase
habitual physical activity in adults with ankylosing spondylitis (AS)? Does the intervention improve
health-related physical fitness, AS-related features, and attitude to exercise? Are any gains maintained
over a 3-month follow-up[19_TD$DIFF]? Design: Parallel-group, randomised, controlled trial with concealed
allocation, assessor blinding and intention-to-treat analysis. Participants: Forty adults with a diagnosis
of AS, on stable medication, and without PA-limiting comorbidities. Intervention: Over a 3-month
period, the experimental group engaged in individually [20_TD$DIFF]-tailored, semi-structured consultations aiming
to motivate and support individuals in participating in PA. The control group continued with usual care.
Outcome measures: The primary outcome was PA measured by accelerometry over 1 week. Secondary
outcomes included clinical questionnaires and measures of health-related physical fitness. Measures
were taken at baseline, post-intervention, and after a 3-month follow-up period. Results: Baseline
characteristics were similar across groups, except age and body composition. There were statistically
significant, moderate-to-large time-by-group effects in health-enhancing PA (mixed-design ANOVA for
overall effect F(2, 76) = 14.826, p < 0.001), spinal mobility (F(2, 76) = 5.691, p < 0.005) and quality of life
(x2 [17_TD$DIFF](2) = 8.400, p < 0.015) favouring the intervention group; post-intervention improvements were
sustained 3months later. No significant effects were seen in other physical fitness outcomes or on clinical
questionnaires. No adverse effects were reported during the study. Conclusion: Health-enhancing PA,
spinal mobility and quality of life were significantly improved after the intervention, and improvements
were maintained at 3-month follow-up. Trial registration: [1_TD$DIFF] NCT02374502. [O’Dwyer T, Monaghan A,
Moran J, O’Shea F, Wilson F (2016) Behaviour change intervention increases physical activity, spinal
mobility and quality of life in adults with ankylosing spondylitis: a randomised trial. Journal of
Physiotherapy 63: 30–39]
 2016 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Ankylosing spondylitis (AS) is a chronic inflammatory rheu-
matic disease that primarily affects the axial skeleton. Clinically, it
is characterised by inflammatory back pain and stiffness, with
decreased spinal mobility, fatigue and limitations in physical
function.1 Accompanying extra-articular features may include
uveitis, osteoporosis, inflammatory bowel disease, psoriasis, and
cardiac, pulmonary and kidney involvement.2 AS is associatedwith
reductions in physical fitness, work productivity and health-
related quality of life.3–5
Physical activity (PA), including therapeutic exercise, is a key
component in the management of AS.6,7 Exercise-based inter-
ventions have been shown to be effective in improving physical
function, mobility, disease activity and quality of life out-
comes.8,9 In addition to these AS-specific benefits, PA has been
shown to reduce the risk of cardiovascular disease, obesity,
some cancers, type 2 diabetes and osteoporosis in the general
population.10 It also improves musculoskeletal health and
reduces symptoms of depression. Despite these benefits,http://dx.doi.org/10.1016/j.jphys.2016.11.009
1836-9553/ 2016 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).individuals with AS tend to have poor compliance with exercise
programs;11,12 the majority of adults with AS do not participate
in regular exercise and may engage in less health-related PA
than the general population.5,12,13 Furthermore, exercise
prescriptions have traditionally focused on flexibility and
mobility.8,9 Without also including aerobic and resistance
components, exercise programs may not elicit the potential
health benefits of PA. 10
The promotion of PA to individuals with chronic conditions,
such as AS, is a key challenge faced by healthcare professionals and
policy makers.7,14–16 International guidelines recommend that
adults obtain at least 150 minutes of moderate-intensity aerobic
PA per week, in bouts of activity lasting at least 10 minutes
(PABOUTS).
6,15 Alternatively, weekly PA recommendations may be
met by performing 75 minutes of vigorous-intensity PA, or by
combining moderate-intensity and vigorous-intensity PA (MVPA).
In addition, strengthening exercises are recommended for all
adults, while balance and coordination exercises are recom-
mended for adults aged > 65 years. Awareness of these guidelines
among individuals with rheumatic conditions is low, and the.V. This is an open access article under the CC BY-NC-ND license (http://
Research 31efficacy of population-based approaches to PA promotion in
reaching individuals with AS is questionable.17
‘Brief intervention’ is a term used to mean verbal advice,
discussion, negotiation or encouragement, involving the provision
of formal help and follow-up; this can vary from basic advice to a
more extended, individually focused discussion.16 National guide-
lines recommend brief interventions as effective methods with
which to bring about health behaviour changes, including
increasing PA.16,18 In sedentary adults, brief interventions have
shown positive short-term and long-term benefits on self-reported
PA.19,20 Although trials have delivered education and exercise-
based interventions in AS cohorts,8,9 it is believed that no study, to
date, has explored strategies to increase habitual PA among
individuals with AS. Thus, the Increasing Physical Activity in
Ankylosing Spondylitis (INPACT-AS) trial was devised.
Therefore, the research questions for this parallel-group,
randomised, controlled trial with concealed allocation, assessor
blinding and intention-to-treat analysis were:1. DTa
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increase habitual PA in adults with AS?2. Does the intervention improve health-related physical fitness,
AS-related features, and attitude to exercise?3. Are any gains maintained over a 3-month follow-up period?
Method
Design
This study was an assessor-blinded, parallel-group, random-
ised, controlled trial conducted between March 2015 and October
2015. Adults with a diagnosis of ASwere randomly allocated either
to individually tailored, semi-structured consultations to encour-
age PA (experimental group) or to usual care (control group) [21_TD$DIFF], for a
3 month period. Eligible participants were randomised using a
computer-generated list of random numbers that had been
prepared using a blocked randomisation model by a researcher
with no involvement in the trial. The allocation sequence was
concealed in sequentially numbered, opaque, sealed envelopes.
Following completion of baseline assessments, the lead researcher
opened the appropriate envelope and assigned participants to their
group. Outcomes were assessed at the end of the 3-month
intervention period and 3 months later.
Participants, therapists and centres
Participants were recruited through the rheumatology outpa-
tient clinics of St [22_TD$DIFF]. James’s Hospital, Dublin, and through patient
support groups. Adults between 18 and 64 years of age who had
been diagnosed by a rheumatologist with AS were eligible for
inclusion in the study if they were on stable pharmacological
management and proficient in English. The exclusion criteriawere:ble 1
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elf-belief Verbal persuasion about capability,a concomitant cardiac, respiratory or neurological condition; a
comorbidity that restricts PA; an acute lower limb injury;
uncontrolled epilepsy; a cognitive impairment; pregnancy;
inability to ambulate without a mobility aid; or a change in
medication during the 6 weeks preceding trial commencement.
Written, informed consent was obtained from each participant
prior to involvement in the study.
Intervention
Participants in the experimental group engaged in a number of
individually tailored consultations with a physiotherapist. The aim
of these sessions was to motivate and support individuals to
participate in PA, taking into account their needs, ambitions,
preferences and available resources. This intervention incorporat-
ed the ‘spirit’ of motivational interviewing, and emphasised
partnership and cooperation between the physiotherapist and
the participant.21 [2_TD$DIFF] Table 1 lists the specific behaviour change
techniques used during the trial;22 not all techniqueswere used for
all participants.
Initial consultations (lasting approximately 30 minutes) were
semi-structured, although three common areas were addressed
with each participant. The first area was education: participants
were provided with an AS information booklet (www.
ankylosing-spondylitis.ie/pdf/SUAS_info_booklet.pdf) and partici-
pants were made aware of PA guidelines. The second area was
resources: participants were provided with information about
community-based programs, hospital-based classes and online
resources. The third areawas goal setting: individual PA goalswere
established, and individualised action plans were devised. Poten-
tial barriers to goal attainment were identified and strategies to
overcome these were discussed.
Follow-up sessions were arranged to review PA behaviour,
monitor progress, review goals and provide support and encour-
agement. The frequency of follow-up sessions and the mode of
follow-up (in person or telephone) were at the discretion of the
participant. Weekly reminders of personal PA goals were sent to
participants by mobile text message or email. If applicable,
participants were granted access to a commercial platforma [3_TD$DIFF] to
view individually tailored exercise programs.
Participants in the control group were informed of their group
allocation by phone, and advised to continuewith their habitual PA
andmedical management. They were only contacted by a member
of the research team to schedule appointments for reassessment.
No restrictions were imposed on beginning new PA routines, and
appointments with healthcare professionals continued as normal.
Outcomes
Assessments were performed at baseline (Month 0), at the
conclusion of the intervention period (Month 3), and following a 3-
month follow-up period (Month 6). All physical fitness testing took
place in the same exercise laboratory; equipment was calibrated
prior to each session. Two physiotherapists trained in administeringons (BCTTv1 labelling).22
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were blinded to participant group allocation, and participants were
instructed not to divulge their group allocation. Participants were
asked to refrain from smoking, eating or drinking for 4 hours, or
engaging in strenuous exercise for 24 hours, prior to assessment
sessions.
Sociodemographic characteristics were ascertained at baseline.
Participants were also asked about symptom duration, time since
diagnosis and current medication usage.
Primary outcome: physical activity
Free-living habitual PA was measured using ActiGraph GT3X
accelerometersb. The validity and reliability of GT3X acceler-
ometers have previously been established.23–25 Participants wore
the small tri-axial accelerometer on their hip during waking hours
over a 7-day period. The monitor was only removed for showering
and swimming, and non-wear timewas documented in a daily log.
The collected data was post-processed in the relevant
softwarec. Wear time validity was determined according to the
algorithm described by Choi et al;26 wear time  10 hours per day
and  4 days (including  1 weekend day) were also specified as
criteria for valid wear time. Output in ‘counts’ was converted to
time spent at different PA intensities according to established
cutpoints.27,28
Secondary outcomes: physical fitness and anthropometry
A comprehensive battery of measures was used to assess
components of health-related physical fitness. Anthropometric
measures included: barefoot standing heightd, masse, and waist
and hip circumferences.29 Body fat percentage was estimated by
whole-body bio-impedance analysise.30 Spinal mobility was
assessed by the Bath Ankylosing Spondylitis Metrology Index.
(BASMI).31,32 Thoracic mobility is underrepresented in the BASMI,
so chest expansionwas additionallymeasured circumferentially at
the fourth intercostal level.33 To assess cardiorespiratory fitness,
participants undertook amultistage, submaximal exercise test on a
treadmill.34 After a 5-minute walking familiarisation period,
participants began an incremental test following the modified
Bruce protocol.35 Breath-by-breath gas analysis and heart rate
were recorded throughoutf. The American College of Sports
Medicine’s metabolic equation was used to estimate VO2max.
36
Finally, a push-up test and a curl-up testwere completed according
to the standardised American College of Sports Medicine
procedures to measure muscular endurance;36 the maximum
number of consecutive repetitions performed without rest was
recorded.
Secondary outcomes: clinical questionnaires
A number of commonly used questionnaires endorsed by the
Assessment of SpondyloArthritis International Society were self-
administered; these have established reliability and validity.33,37
The Bath Ankylosing Spondylitis Global score (BAS-G) measured
global well-being over the previousweek and previous 6months.38 [23_TD$DIFF]
Disease activity was measured on the Bath Ankylosing Spondylitis
Disease Activity Index (BASDAI).37,39 The Bath Ankylosing Spon-
dylitis Functional Index (BASFI) assessed activities of daily living
and functional ability.40
Additional questionnaires, not part of the Assessment of
SpondyloArthritis International Society core set, were also
administered. The Ankylosing Spondylitis Quality of Life Ques-
tionnaire (ASQoL) was used tomeasure the impact of AS on health-
related quality of life.41 Each participant’s rating of their ability to
manage their condition was measured using the AS version of the
Arthritis Self-efficacy Scale (ASES-AS);42 a higher mean score on
the eight-item scale indicated higher self-efficacy. Each partici-
pant’s perception of exercisewas assessed using amodified version
of the Exercise Benefits and Barriers Scale (EBBS).43 The modified
EBBS included 29 ‘benefit’ items and 13 ‘barrier’ items, with
possible total scores ranging from 42 to 168; higher scores
indicated a more positive perception of exercise.Data analysis
Statistical analyses were performed with commercial
softwareg. As this study was exploratory in design, no formal
sample size consideration was performed. Data were analysed
using an intention-to-treat analysis. Missing data were imputed
with the last-observation-carried-forward approach. For all
analyses, p < 0.05 (two-tailed) was taken as statistically signifi-
cant. Normality of distributions was assessed using the Shapiro-
Wilk normality test, in addition to visual evaluation of histograms
and normal Q-Q plots of residuals. Descriptive statistics were used
to report participant characteristics at baseline.
The main statistical analyses were performed using mixed-
design repeated measures analysis of variance (ANOVA). A series of
3 x 2 ANOVAs (time: baseline versus post-intervention versus
follow-up; group: intervention versus control) with repeated
measures on the first factor and Bonferroni correction for multiple
comparisons were run to assess the effects of the intervention on
each of the outcome variables separately. One-way repeated
measures ANOVAs were run to compare within-group main effects
at each time point. Effect sizes were classified as small, medium or
large (partial h2 < 0.01,< 0.06,< 0.14, respectively).44 If the
assumptions of ANOVA were violated, data were transformed
(square root or log10 transformations). If data transformation did
not address the violations of assumptions for ANOVAs, data were
analysed using related-samples Friedman’s Two-way Analysis of
Variance by Ranks test; separate Wilcoxon Signed-rank tests were
used to identify within-group differences, and Mann-Whitney U
tests were used to assess between-group differences at each time
point.
Results
Compliance with the study protocol
Subsequent to protocol registration, costs associated with
collection and processing of venous blood samples became
prohibitively expensive. Consequently, inflammatory blood mar-
kers (C-reactive protein and erythrocyte sedimentation rate) were
unavailable for the planned calculation of Ankylosing Spondylitis
Disease Activity Scores.
Three participants were unable to attend the exercise laboratory
for their post-intervention reassessment because of work commit-
ments. One non-attendee from each group completed the self-
report questionnaires and wore the PA monitor for 1 week,
returning these by post. Five participants (three from the
intervention group and two from the control group) were unable
to attend the exercise laboratory for their follow-up assessment
(work commitments n = 2, emigrated n = 1, did not attend n = 1, not
contactable n = 1). Two of these non-attendees (one from each
group) completed the self-report questionnaires and wore the PA
monitor for 1 week, and returned them by post. Analysis of which
data were missing showed that the curl-up and push-up tests had
the largest numbers ofmissing values across the three test sessions;
participantswere unwilling, or felt unable, to attempt these tests. In
light of the high number of missing cases, a complete case analysis
was deemed appropriate for these strength outcomes.
Flow of participants, therapists and centres through the study
Recruitment for the trial concluded in April 2015. The partici-
pant flow through the study is summarised in Figure 1. A total of
44 potential volunteers were screened for inclusion in the study.
Forty participants meeting the eligibility criteria were randomised
to the intervention group (n = 20) and the control group (n = 20).
Baseline characteristics
The two groups of participants were similar with respect to
baseline sociodemographic characteristics, symptom duration,
[(Figure_1)TD$FIG]
Control group 
• usual care 
• advice to continue usual 
PA but no restriction on 
beginning new PA 
routines 
Adults assessed for eligibility (n = 44) 
Excluded (n = 4) 
• ineligible (n = 2) 
• declined to participate (n = 2) 
Measured sociodemographic data, PA, physical fitness measures and questionnaires 
Randomised (n = 40) 
(n = 20)               (n = 20) 
Month 0 
Experimental group 
• individual physiotherapy 
consultation sessions to 
promote PA behaviour 
change 
• other usual care
Month 3 
Measured PA, physical fitness measures and questionnaires 
 (n = 19)                (n = 20) 
Intention-to-treat analysis 
(n = 20)                (n = 20) 
Measured PA, physical fitness measures and questionnaires 
 (n = 17) 
a
               (n = 19) 
b
Intention-to-treat analysis 
(n = 20)                (n = 20)  
Month 6 
Lost to follow-up 
• did not attend 
(n = 1) 
Lost to follow-up 
(n = 0) 
Lost to follow-up 
• did not attend 
(n = 1)  
• not contactable 
(n = 1) 
Lost to follow-up 
• did not attend 
(n = 1)  
Figure 1. Design and flow of participants through the trial.
a Complete case analysis for muscular strength (n = 9 to 14).
b
[9_TD$DIFF] Complete case analysis for muscular strength (n = 7 to 13).
Research 33time since diagnosis, condition-related features (Table 2), PA
measures ( [5_TD$DIFF]see[6_TD$DIFF] Table 3[24_TD$DIFF] on the eAddenda) and physical fitness
measures ([7_TD$DIFF]see [6_TD$DIFF] Table 4[25_TD$DIFF] on the eAddenda).
Engagement with intervention protocol
During the 3-month intervention, participants in the interven-
tion group consulted with a physiotherapist a median of five times
(IQR 4 to 5, range 2 to 6). Initial consultations were all in person.
The median number of follow-up consultations was 4 (IQR 3 to 4),
and 62% of these follow-up sessions were by phone (median 2, IQR
1 to 3). No adverse effects were reported as a consequence of the
intervention.
Primary outcome: physical activity
There were large, statistically significant time-by-group effects
for MVPA and PABOUTS (Table 5). In the intervention group, there
were statistically significant differences in MVPA and PABOUTS
between baseline and post-intervention (p = 0.027 and p = 0.011,
respectively), and between baseline and follow-up (p = 0.029 and
p = 0.009); this indicated a sustained increase in these variables
over the follow-up period. In the control group, significant
decreases in MVPA and PABOUTS were observed between the
baseline and 3-month follow-up (p = 0.026 and p = 0.013, respec-
tively). The between-group comparisons for the changes in these
outcomes were statistically significant, indicating an effect of theintervention (see the last three columns of Table 5). No significant
differences in time spent sedentary or engaging in light PA were
observed across time points, indicating that the intervention had
no significant effect on sedentary behaviour. At the end of the
follow-up phase there were significantly more participants in the
intervention group meeting the PA guidelines than in the control
group (intervention group = 14, control group = 3; Pearson Chi-
squared (1) = 12.379, p < 0.001). The experimental intervention
significantly increased the likelihood of meeting the PA guidelines
(RR 4.7, 95% CI 1.6 to 13.8).
Secondary outcome variables
Physical fitness
There was amoderate-to-large statistically significant time-by-
group interaction effect for the BASMI (Table 6). In the intervention
group, there was a significant decrease in BASMI score between
baseline and post-intervention (p < 0.0005), and baseline and
follow-up (p < 0.0005). In the control group, there were no
significant differences in BASMI scores. In both groups, significant
differences in the push-up test across the three time points were
observed. In the control group, there was also a statistically
significant difference in cardiorespiratory test duration. Post-hoc
analyses did not show significant differences in these outcomes
when Bonferroni corrections were applied. There were no
significant time-by-group interaction effects for other physical
fitness outcomes.
Table 2
Baseline characteristics of participants.
Characteristic Total (n =40) Exp (n=20) Con (n=20)
Age (yr), mean (SD) 42 (9) 39 (8) 45 (10)
Gender, n males (%) 26 (65) 13 (65) 13 (65)
Caucasian, n (%) 40 (100) 20 (100) 20 (100)
Employed full time, n (%) 34 (85) 17 (85) 17 (85)
Tertiary educated, n (%) 30 (75) 17 (85) 13 (65)
Married, n (%) 23 (58) 10 (50) 13 (65)
Dependents (n), median (IQR) 1 (0 to 2) 1 (0 to 2) 1 (0 to 2)
Smoker, n (%) 3 (8) 2 (10) 1 (5)
Residence, n (%)
urban 37 (93) 18 (90) 19 (95)
rural 3 (8) 2 (10) 1 (5)
Symptom duration (yr), mean (SD) 21 (12) 18 (10) 24 (14)
Time since diagnosis (yr), median (IQR) 9 (5 to 20) 8 (5 to 13) 10 (5 to 22
Medications (n), median (IQR) 1 (0 to 2) 1 (0 to 1) 1 (0 to 2)
Medications, n (%)
none 10 (25) 5 (25) 5 (25)
anti-TNFa 22 (55) 11 (55) 11 (55)
NSAIDs 12 (30) 6 (30) 6 (30)
DMARD 2 (5) 0 (0) 2 (10)
analgesia 2 (5) 0 (0) 2 (10)
other 7 (18) 4 (20) 3 (15)
Back pain, total (0 to 10), median (IQR) 3.0 (1.0 to 4.0) 3.0 (2.0 to 4.0) 2.5 (0 to 4.0)
Back pain, night (0 to 10), median (IQR) 2.0 (0.3 to 4.0) 2.0 (1.0 to 3.9) 2.0 (0 to 4.8)
Global disease activity (0 to 10), median (IQR) 3.0 (2.0 to 4.0) 3.0 (2.0 to 4.0) 2.0 (1.3 to 3.0)
Bath AS-Global (BAS-G) score (0 to 10), mean (SD) 3.0 (2.0) 3.0 (1.8) 3.1 (2.2)
Bath AS Disease Activity Index (BASDAI) (0 to 10), mean (SD) 3.2 (1.7) 3.4 (1.6) 3.0 (1.8)
Bath AS Functional Index (BASFI) (0 to 10), median (IQR) 1.8 (0.5 to 3.5) 1.4 (0.5 to 3.3) 2.3 (0.7 to 4.0)
AS Quality of Life (ASQoL) questionnaire (0 to 18), mean (SD) 4.8 (3.2) 5.1 (3.6) 4.5 (2.9)
AS version of the Arthritis Self-efficacy Scale (ASES-AS) (0 to 10), mean (SD) 6.7 (1.7) 6.5 (1.6) 6.9 (1.8)
ASES-AS=Arthritis Self-efficacy Scale-Ankylosing Spondylitis version, ASQoL=Ankylosing Spondylitis Quality of Life questionnaire, BASDAI=Bath Ankylosing Spondylitis
Disease Activity Index, BASFI =Bath Ankylosing Spondylitis Functional Index, BAS-G=Bath Ankylosing Spondylitis Patient Global score, Con= control group,
DMARD=disease-modifying antirheumatic drugs, Exp=experimental group, NSAIDs =non-steroidal anti-inflammatories, TNFa= tumour necrosis factor alpha.
Some percentages do not sum to 100 due to the effects of rounding or because some patients were on multiple medications.
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In the intervention group, there was a statistically significant
difference in the ASQoL score over time (Table 7). Post hoc
analyses, with Bonferroni corrections applied, showed a statisti-
cally significant decrease in the ASQoL score from baseline to post-
intervention (p = 0.007), and from baseline to follow-up
(p = 0.008). This indicated that the intervention improved AS-
related quality of life. In the control group, there was also a
statistically significant difference in the ASQoL, but post hoc
analyses did not show significant differences in ASQoL score
between time points when the Bonferroni correction was applied.
There were no statistically significant time-by-group interaction
effects for the other questionnaire outcomes.
Discussion
This randomised, controlled trial was the first to implement a
behaviour change intervention targeting PA in an AS cohort. The
results of this study demonstrated that an individually tailored
brief intervention that targets PA increases habitual health-
enhancing PA, and that this is sustained over a 3-month period.
Brief intervention – as a strategy to increase PA – was well
tolerated by individuals with AS who were able to moderate their
chosen activities to match their personal abilities. After the
intervention, 70% of the intervention group were adhering to the
aerobic PA guidelines. This was significantly higher than the
adherence rates in the control group, and higher than previously
reported rates in AS cohorts45 [4_TD$DIFF] and the general Irish population.46
Results from this study suggest that for every two people with AS
who received the intervention, one of them will meet the PA
guidelineswho otherwisewould not havemet them (95% CI 1 to 4).
Secondary aims of the trial were to explore the effects of a PA
behaviour change intervention on health-related physical fitness
and on condition-related clinical outcomes. Importantly for
individuals with AS, the brief intervention in this trial generated
a moderate improvement in spinal mobility scores. This wasachieved without implementing a specific flexibility program.
Rather, participants selected exercises and activities that would
help achieve their individual PA goals, which tended to be focused
on functional tasks, aerobic exercise, or sporting activities. Other
components of physical fitness (body composition, cardiorespira-
tory capacity and muscular fitness) did not significantly improve
over the course of the study. The intervention targeted PA, and the
dosage of exercise may not have been sufficient to generate
physiological changes in these domains. The intervention showed
benefits beyond PA and spinal mobility improvements; quality of
life significantly improved from baseline to the end of the
intervention, and this improvement was sustained at the 3-month
follow-up.
Despite the numerous benefits of PA, compliance with exercise
programs and participation in PA among individuals with AS are
low.11,45 [26_TD$DIFF] Individuals with AS have proposed individually tailored
interventions, collaboratively developed with healthcare profes-
sionals, as an effective strategy to PA and exercise prescription.47
By incorporating this approach to PA promotion, this studywas the
first to demonstrate a significant, sustained positive effect on PA in
adults with AS. Given the treatment effects of increased PABOUTS,
improved spinal mobility and enhanced quality of life, against a
background of stable self-reported disease activity, brief interven-
tion as an approach to the management of people with AS appears
to be safe, practical and beneficial. The adaptable nature of the
intervention and the flexible approach to follow-up sessions
facilitated engagement with the intervention. Similarly, such a
self-directed approach has been successfully used to promote PA in
the general population19 and among people with rheumatoid
arthritis.48 Brief interventions require fewer resources than more
intensive interventions such as exercise classes, and can be readily
replicated in primary care or hospital settings. Brief interventions
targeting PA behaviour are an alternate treatment option for
clinicians working with individuals with AS.
Further clarification as to which behaviour change techniques
generate the greatest effects and which, if any, are redundant, is
Table 5
Mean (SD) of groups, mean (SD) difference within groups, and overall effect size on physical activity outcomes.
Outcome Groups Difference within groups Difference between
groups
Month 0 Month 3 Month 6 Month 3 minus month 0 Month 6 minus month 0 Overall effect a
Exp (n=20) Con (n=20) Exp (n=20) Con (n=20) Exp (n=20) Con (n=20) Exp Con Exp Con F b p-value c Effect
size d
Sedentary activity
(minutes/week)
3800 (629) 3564 (790) 3600 (535) 3546 (760) 3755 (543) 3575 (722) –140 (515) –18 (547) –46 (627) –11 (489) 0.266 0.767 0.007
Sedentary time
(% of total
wear time)
65 (10) 60 (12) 64 (11) 62 (11) 63 (10) 63 (10) –1 (7) 1 (8) –1 (6) 3 (7) 2.405 0.097 0.060
Light physical activity
(minutes/week)
1799 (495) 2022 (642) 1755 (606) 1894 (599) 1885 (610) 1818 (594) –44 (360) –128 (422) 87 (374) –203 (514) 2.473 0.091 0.061
Moderate/vigorous
physical activity
(minutes/week) e
238 (72 to 382) 302 (196 to 479) 309 (171 to 448) 298 (185 to 429) 296 (177 to 446) 197 (160 to 288) 67 (11 to 137) 14 (-53 to 51) 58 (-4 to 146) –65 (-155 to 17) 9.776 < 0.001 0.205
Moderate/vigorous
physical activity
in bouts  10minutes
(minutes/week) e
124 (4 to 230) 173 (46 to 234) 192 (119 to 308) 142 (50 to 193) 198 (144 to 315) 69 (40 to 114) 72 (8 to 155) -6 (-64 to 10) 53 (1 to 162) –72 (-139 to 1) 14.826 < 0.001 0.281
Total wear time
(minutes/week)
5868 (435) 5920 (499) 5705 (509) 5758 (523) 5974 (636) 5642 (656) –164 (465) –162 (505) 105 (742) –278 (661) 2.647 0.082 0.065
Con= control group, Exp=experimental group.
a 3 x 2 analysis of variance.
b Mixed-design analysis of variance F-ratio, representing interaction effect of time by group on dependent variable [11_TD$DIFF].
c Significant p-value < [12_TD$DIFF]0.05.
d Partial h2[10_TD$DIFF]: small > 0.01, medium > 0.06, large > [13_TD$DIFF]0.14.
e Data presented are median (IQR), median change (IQR) and overall effect [14_TD$DIFF].
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Table 6
Mean (SD) of groups, mean (SD) difference within groups, and overall effect size on physical fitness and anthropometry outcomes.
Outcome Groups Difference within groups Difference between groups
Month 0 Month 3 Month 6 Month 3 minus month 0 Month 6 minus month 0 Overall effect a
Exp (n=20) Con (n=20) Exp (n=20) Con (n=20) Exp (n=20) Con (n=20) Exp Con Exp Con F b p-value c Effect
size d
Cardiorespiratory ftness
VO2max (ml/min/kg) 42.5 (9.1) 38.9 (8.5) 42.3 (10.0) 38.9 (10.4) 42.0 (9.6) 37.8 (8.6) –0.1 (4.6) 0.0 (6.3) –0.5 (4.9) –1.1 (6.9) 0.095 0.910 0.002
Test duration (s) e 857 (756 to 934) 781 (662 to 872) 919 (747 to 947) 815 (725 to 905) 920 (756 to 948) 789 (742 to 917) 0 (-16 to 69) 56 (3 to 125) 21 (-12 to 73) 26 (-1 to 111) 1.701 f
8.44 g
0.427
0.015
N/A
N/A
Body composition
Mass (kg) 74.2 (12.5) 76.7 (11.6) 73.6 (11.8) 76.4 (11.5) 74.1 (11.8) 76.3 (11.8) –0.6 (2.9) –0.4 (1.6) –0.1 (2.6) –0.5 (2.6) 0.332 0.656 0.009
Body mass index (kg/m) 23.9 (3.8) 26.9 (3.6) 23.7 (3.5) 26.7 (3.7) 24.0 (3.5) 26.7 (3.9) –0.2 (0.9) –0.1 (0.5) 0.0 (0.8) –0.2 (0.9) 0.674 0.486 0.017
Waist circumference (cm) 84.7 (8.3) 90.9 (10.1) 84.4 (8.4) 91.4 (11.6) 84.2 (9.1) 91.1 (12.0) –0.3 (6.1) 0.5 (6.0) –0.5 (4,8) 0.2 (6.3) 0.122 0.867 0.003
Hip circumference (cm) 99.9 (6.6) 103.3 (6.5) 99.1 (6.2) 101.1 (5.7) 98.8 (6.5) 100.9 (6.7) –0.8 (1.9) –2.2 (2.4) –1.1 (1.9) –2.4 (3.2) 2.237 0.114 0.056
Body fat (%) 21.9 (7.7) 26.9 (7.4) 21.5 (8.5) 26.4 (7.1) 22.1 (7.9) 26.9 (6.9) –0.4 (2.4) –0.4 (1.4) 0.1 (1,5) 0.0 (1.9) 0.016 0.984 <0.001
Muscular fitness
Push-up Test (n) e 18 (11 to 28) 14 (8 to 24) 29 (19 to 31) 20 (10 to 27) 21 (20 to 30) 19 (12 to 30) 8 (5 to 14) 4 (1 to 10) 7 (1 to 12) 3 (3 to 11) 18.111f
7.680g
<0.001
0.021
N/A
N/A
Curl-up Test (0 to 25), (n) e 20 (12 to 25) 20 (9 to 24) 23 (20 to 25) 21 (20 to 25) 22 (19 to 25) 20 (17 to 25) 2 (–2 to 8) 2 (–4 to 12) 5 (–2 to 6) 2 (–7 to 6) 1.152f
1.04 g
0.562
0.595
N/A
N/A
Flexibility
Chest expansion (cm) 4.8 (1.2) 4.2 (2.2) 5.5 (2.2) 4.7 (2.1) 6.0 (2.0) 5.3 (1.8) 0.6 (2.1) 0.5 (1.7) 1.1 (1.9) 1.1 (2.4) 0.029 0.971 <0.001
BASMI total score (0 to 10) 2.3 (1.1) 2.9 (1.3) 1.8 (1.0) 2.7 (1.4) 1.7 (1.0) 2.8 (1.4) –0.5 (0.4) –0.2 (0.4) –0.6 (0.5) –0.1 (0.5) 5.691 0.005 0.130
BASMI=Bath Ankylosing Spondylitis Metrology Index of spinal mobility, Con= control group, Exp=experimental group.
a 3 x 2 analysis of variance.
b Mixed-design analysis of variance F-ratio, representing interaction effect of time by group on dependent variable [11_TD$DIFF].
c Significant p-value < [12_TD$DIFF]0.05.
d Partial h2[10_TD$DIFF]: small > 0.01, medium > 0.06, large > [13_TD$DIFF]0.14.
e Data presented are median (IQR), median change (IQR) and overall effect.
f Data remained non-parametric after transformation so Friedmans’ two-way analysis of variance by ranks is reported for the intervention group [15_TD$DIFF].
g Data remained non-parametric after transformation so Friedmans’ two-way analysis of variance by ranks is reported for the control group.
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Table 7
Mean (SD) of groups, mean (SD) difference within groups, and overall effect size on condition-related outcomes and attitudes to exercise.
Outcome Groups Difference within groups Difference between
groups
Month 0 Month 3 Month 6 Month 3 minus month 0 Month 6 minus month 0 Overall effect a
Exp (n=20) Con (n=20) Exp (n=20) Con (n=20) Exp (n=20) Con (n=20) Exp Con Exp Con F b p-value c Effect
size d
Bath AS – Global (BAS-G)
score (0 to 10)
3.0 (1.8) 3.1 (2.2) 3.1 (2.2) 2.9 (1.7) 2.9 (1.9) 3.0 (1.8) 0.1 (1.3) –0.2 (1.6) –0.1 (1.6) –0.0 (1.1) 0.315 0.730 0.008
Bath AS Disease Activity
Index (BASDAI) (0 to 10) e
3.2 (2.5 to 4.9) 2.8 (2.2 to 3.9) 2.7 (1.3 to 5.0) 2.4 (1.2 to 3.3) 2.2 (1.6 to 5.0) 2.5 (1.8 to 4.2) –0.1 (–1.1 to 0.5) –0.3 (–1.4 to 0.6) –0.8 (–1.3 to 0.2) –0.1 (–0.6 to 0.3) 3.534 f
0.50 g
0.171
0.779
N/A
N/A
Bath AS Functional Index
(BASFI) (0 to 10) e
1.4 (0.5 to 3.3) 2.3 (0.7 to 4.0) 1.0 (0.5 to 2.7) 1.9 (0.6 to 3.7) 0.6 (0.3 to 2.5) 2.4 (0.7 to 4.0) 0 (–0.5 to 0.5) –0.2 (–0.8 to 0.2) –0.1 (–0.1 to 0.5) 0 (–0.6 to 0.6) 3.545 f
1.34 g
0.170
0.511
N/A
N/A
AS Quality of Life (ASQoL)
questionnaire (0 to 18) e
5.0 (2.5 to 6.0) 4.5 (2.3 to 7.0) 2.0 (0.3 to 5.8) 3.0 (2.0 to 4.8) 2.5 (0.0 to 5.8) 4.0 (1.0 to 6.0) –1.5 (–3.8 to 0) –1.0 (–3.0 to 0) –2.0 (–4.0 to 0) –0.5 (–1.9 to 0) 8.400 f
6.43 g
0.015
0.040
N/A
N/A
AS version of the Arthritis
Self-efficacy Scale
(ASES-AS) (0 to 10)
6.5 (1.6) 6.9 (1.8) 7.0 (1.2) 7.5 (1.8) 7.2 (1.7) 7.0 (2.0) 0.5 (2.0) 0.6 (1.1) 0.7 (2.2) 0.1 (1.4) 0.927 0.400 0.024
Exercise Benefits and Barriers Scale (EBBS)
Total (42 to 168) 135.3 (16.3) 137.6 (14.3) 141.9 (10.0) 142.7 (15.0) 141.5 (13.5) 142.8 (15.4) 6.7 (13.1) 5.1 (7.8) 6.2 (12.7) 5.2 (8.1) 0.136 0.873 0.004
Benefits (29 to 116) 94.5 (11.8) 97.0 (10.8) 98.6 (8.2) 100.2 (11.0) 98.0 (10.5) 100.4 (11.1) 4.1 (9.5) 3.1 (6.6) 3.6 (9.4) 3.3 (6.2) 0.098 0.906 0.003
Barriers (13 to 52) 25.7 (6.3) 23.7 (4.9) 22.7 (3.8) 21.7 (5.3) 22.6 (5.2) 21.8 (5.3) –2.6 (4.9) –2.0 (2.5) –2.7 (4.5) –1.9 (2.6) 0.288 0.734 0.008
AS=ankylosing spondylitis, Con= control group, Exp=experimental group.
a 3 x 2 analysis of variance[10_TD$DIFF].
b Mixed-design analysis of variance F-ratio, representing interaction effect of time by group on dependent variable [11_TD$DIFF].
c Significant p-value < [12_TD$DIFF]0.05.
d Partial h2[16_TD$DIFF]: small > 0.01, medium > 0.06, large > [13_TD$DIFF]0.14.
e Data presented are median (IQR), median change (IQR) and overall effect.
f Data remained non-parametric after transformation so Friedmans’ two-way analysis of variance by ranks is reported for the intervention group.
g Data remained non-parametric after transformation so Friedmans’ two-way analysis of variance by ranks is reported for the control group.
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O’Dwyer et al: Physical activity in ankylosing spondylitis38needed. Future studies should also investigate the relative effects
of different frequencies and durations of consultations, establish
the optimal make up of follow-up sessions, and examine the effect
of combining brief intervention for increasing PA with structured
exercise classes. The feasibility and efficacy of a fully remote
intervention (without face-to-face consultations) should be
explored. Future studies should investigate the optimal timing
for starting the intervention, and identify sub-groups that may be
most amenable (or resistant) to this form of intervention. The
efficacy of the intervention among individuals who are ambivalent
or resistant to PA behaviour change remains to be ascertained. A
full cost-benefit analysis of the intervention was not conducted,
although community-based brief interventions to promote PA in
the general population are cost-effective.49
Because of the exploratory nature of this study, an a priori
sample size calculation was not performed. Consequently, this
study may have been underpowered, and a larger study is
recommended to replicate the findings. Nevertheless, the trial
demonstrated that the benefits accrued over the course of the
intervention were sustained for 3 months; the longer-term effects
of the intervention remain unknown. The cohort of participants
recruited to this trial had relatively low BASFI scores; results may
not be generalisable to individuals with more severe forms of AS,
whose functional limitation may limit their ability to be physically
active. In dealing with missing data, the imputation methods that
were used may have introduced bias into the results by failing to
account for the uncertainty due to the missing data. Another
limitation was the lack of blinding of participants and therapists.
However, a strength of this study was that over its 6-month
duration there were just three dropouts. Missing data were
deemed to be missing completely at random, and so unlikely to
bias the data set.
In conclusion, this was the first study to implement a brief
intervention targeting PA behaviour in a cohort of individuals with
AS. The intervention led to significant increases in health-
enhancing PA, improved spinal mobility and increased quality of
life, compared to controls. These improvements were sustained for
3 months.What is already known on this topic: Among people with
ankylosing spondylitis, exercise improves physical function,
mobility, disease activity and quality of life. The majority of
peoplewith ankylosing spondylitis donot participate in regular
exercise.
What this study adds:Abrief intervention of counselling and
goal setting to increasephysical activity canbeused repeatedly
over 3months to significantly improve physical activity, spinal
mobility and quality of life in people with ankylosing spondy-
litis. These benefits appear to be maintained 3 months later.Footnotes: aSalaso, Salaso Healthcare Solutions, Limerick,
Ireland, bGT3X accelerometers, ActiGraph, Pensacola, USA, cActi-
Life software V.6, ActiGraph, Pensacola, USA, dLeicester portable
heightmeasure, Invincta Plasics, Leicester, UK, eMC-180MA, Tanita
Corp, Tokyo, Japan, fQuark, Cosmed, Rome, Italy, gSPSS for
Windows V.22, IBM, Armonk, NY, USA
eAddenda: Tables 3 and 4 can be found online at doi:10.1016/j.
jphys.2016.11.009
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